| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6182885 | Gynecologic Oncology | 2012 | 7 Pages |
Abstract
⺠Meta-analysis of ten studies with 1815 ovarian cancer patients confirms a significant survival advantage associated with tumor-infiltrating lymphocytes (TIL). ⺠This effect was demonstrated across diverse patient cohorts regardless of the tumor grade, stage, or histologic subtype studied. ⺠A standardized measure of CD8+ TILs in ovarian cancer will facilitate the clinical use of this robust biomarker.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Wei-Ting Hwang, Sarah F. Adams, Emin Tahirovic, Ian S. Hagemann, George Coukos,